Video Experimental Relacionado
Updated: Sep 8, 2025
15:05
Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
8.8K
Orientación hacia la señalización patológica de ERK1/2 en el cáncer y más allá
Constanze Schanbacher1, Maria-Elisabeth Goebeler2, Brenda Gerull3
1Institute of Pharmacology and Toxicology, University of Würzburg, 97078 Würzburg, Germany.
Trends in molecular medicine
|September 6, 2025
Resumen
Dirigirse a la vía RAF-MEK-ERK1/2 ofrece nuevas estrategias terapéuticas para enfermedades más allá del cáncer. Las lecciones del desarrollo de fármacos contra el cáncer informan tratamientos para afecciones como las RASopatías que involucran desregulación de ERK1/2.
Área de la Ciencia:
- Biología molecular
- En el campo de la oncología
- La genética
Sus antecedentes:
- La vía RAF-MEK-ERK1/2 es crucial en la señalización celular y su desregulación contribuye a varias enfermedades, especialmente el cáncer.
- Se han desarrollado terapias dirigidas contra esta vía para el cáncer, lo que lleva a una mayor comprensión de las funciones de ERK1/ 2.
Objetivo del estudio:
- Revisar los últimos avances en la orientación de las MEK1/2 y ERK1/2 quinasas.
- Explorar la aplicación de los conocimientos de la terapia del cáncer a otras enfermedades con implicación de la vía ERK1/2.
Principales métodos:
- Revisión de la literatura centrada en las estrategias de orientación de MEK y ERK.
- Análisis del desarrollo de fármacos, resultados clínicos y mecanismos de resistencia en el tratamiento del cáncer.
- Exploración de la desregulación de ERK1/2 en condiciones no cancerosas.
Principales resultados:
- La orientación de MEK1/2 y ERK1/2 ha demostrado ser prometedora en el tratamiento del cáncer, dando valiosos datos sobre la modulación de la vía.
- La comprensión de las funciones fisiológicas y patológicas de ERK1/2 se ha ampliado significativamente a través de la investigación del cáncer.
- Está surgiendo el potencial para reutilizar estas estrategias terapéuticas para trastornos genéticos como las RASopatías.
Conclusiones:
- Dirigirse a la vía RAF-MEK-ERK1/2 es un campo dinámico con implicaciones que van más allá de la oncología.
- Las ideas obtenidas de las terapias contra el cáncer proporcionan una base para nuevos enfoques de tratamiento en otros trastornos relacionados con ERK1/2.
- La investigación adicional sobre la orientación de MEK y ERK puede abrir nuevas vías terapéuticas para una gama más amplia de enfermedades.
Videos de Conceptos Relacionados
02:38Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
01:19Interactions Between Signaling Pathways
6.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
01:07MAPK Signaling Cascades
6.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.0K
01:22PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.9K